# Are weight loss clinics still relevant in the Ozempic era? VLCC thinks so

An episode of [Daybreak](https://invisiblenetwork.ai/podcast/1658118308), 3 Mar 2026, 13 min.

Audio: https://media.transistor.fm/149c090e/18499223.mp3

When Ozempic began changing how the world lost weight, most slimming companies panicked. But VLCC didn’t. Backed by Carlyle, it’s opening more clinics than ever before. Because to Carlyle, Ozempic isn’t a threat—it’s just another doorway into India’s beauty economy. In this episode, we look at how VLCC’s new owners are turning an existential challenge into expansion, why its products are taking a back seat to real estate, and what the future of India’s weight-loss industry looks like in the age of GLP-1 drugs. Tune in. *This episode was originally published on November 12th 2025 Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.
